These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 10462128

  • 1. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA, Nguyen HQ, Geiger A.
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [Abstract] [Full Text] [Related]

  • 2. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE, Boikess S, Luo B, Dawson LA.
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A, Millan MJ.
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [Abstract] [Full Text] [Related]

  • 8. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA, Nguyen HQ.
    Neuropharmacology; 2000 Apr 03; 39(6):1044-52. PubMed ID: 10727715
    [Abstract] [Full Text] [Related]

  • 9. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2007 Nov 03; 21(8):795-804. PubMed ID: 17984160
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
    Gartside SE, Umbers V, Sharp T.
    Psychopharmacology (Berl); 1997 Apr 03; 130(3):261-8. PubMed ID: 9151361
    [Abstract] [Full Text] [Related]

  • 11. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA, Li P.
    J Neural Transm (Vienna); 2003 Jun 03; 110(6):577-90. PubMed ID: 12768354
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P.
    J Clin Psychiatry; 2001 Jun 03; 62 Suppl 15():12-7. PubMed ID: 11444761
    [Abstract] [Full Text] [Related]

  • 13. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep 03; 358(3):315-22. PubMed ID: 9774218
    [Abstract] [Full Text] [Related]

  • 14. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
    Bandoh T, Hayashi M, Ino K, Takada S, Ushizawa D, Hoshi K.
    Eur Neuropsychopharmacol; 2004 Dec 03; 14(6):471-8. PubMed ID: 15589386
    [Abstract] [Full Text] [Related]

  • 15. Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats.
    Bjorvatn B, Fornal CA, Martín FJ, Metzler CW, Jacobs BL.
    Eur J Pharmacol; 2000 Sep 15; 404(1-2):121-32. PubMed ID: 10980270
    [Abstract] [Full Text] [Related]

  • 16. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P, Nomikos GG, Svensson TH.
    Br J Pharmacol; 1997 Dec 15; 122(8):1639-46. PubMed ID: 9422809
    [Abstract] [Full Text] [Related]

  • 17. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ.
    Neuroscience; 1999 Mar 07; 93(4):1251-62. PubMed ID: 10501449
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.